Clinical Trials Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 28, 2018; 24(12): 1343-1352
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1343
Table 2 Comparison of the general situation of patients in the peripheral neuropathy and no peripheral neuropathy groups
ItemPeripheral neuropathy groupNo peripheral neuropathy groupt/c2P value
Age in yr50.50 ± 13.9045.00 ± 12.404.6530.000
Sex, % male50.6049.500.0680.795
Systolic blood pressure in mmHg130.17 ± 18.98128.35 ± 20.320.9890.323
Diastolic blood pressure in mmHg75.34 ± 10.3277.02 ± 9.45-1.8800.061
BMI in kg/m219.26 ± 2.1521.88 ± 2.27-12.7030.000
Gastroscopy results, % prevalence of chronic atrophic gastritis76.50%59.20%15.4180.000
Helicobacter pylori infection, %86.4056.4046.4520.000
Gastric acid in mmol6.80 ± 3.7017.80 ± 3.50-33.5700.000
Serum gastrin in pg/mL532.42 ± 167.33208.43 ± 44.1236.9680.000
Serum creatinine in μmol/L78.60 ± 17.2076.50 ± 12.401.6430.101
VitA in ng/mL0.267 ± 0.2690.383 ± 0.336-3.9440.000
VitB1 in nmol/L79.40 ± 20.7082.60 ± 17.50-1.8840.060
VitB6 in mmol/L30.90 ± 14.8032.70 ± 15.60-1.2690.205
VitB9 in ng/mL9.06 ± 3.8110.60 ± 3.27-2.4950.013
VitB12 in pg/mL170.20 ± 111.20216.40 ± 149.80-2.7310.007
VitE in μmol/L31.60 ± 5.4833.20 ± 6.37-1.3460.181